// App-Quantinova.ai

204 : Real-World Evidence: Clinical and Economic Burden of Anemia, Venous Thromboembolism, and Malignancy Among Rheumatoid Arthritis Patients Switching from First Biologic DMARD to Another Treatment in the US

Researchers

Presenter

  • Jenya Antonova

Principal Investigators

  • Magdaliz Gorritz

  • Lawrence Chang

  • Jing He

  • Mark Genovese

Medical Centers

  • Private practice, Tustin, CA

  • Gilead Sciences, Inc., Foster City, CA

  • IQVIA, Plymouth Meeting, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Rheumatoid arthritis

  • Skin carcinoma

  • Inflammatory Arthritis

  • Anemia

  • Solid malignancies

Biomarkers

  • Janus kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved